§ PHARMACEUTICALS
USD · PharmaceuticalsNMRA
NEUMORA THERAPEUTICS INC
USDSector · Pharmaceuticals
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
68 increased/new, 27 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Siren, L.L.C. | 8.5M | 0.5% | +35% |
| SOFTBANK GROUP CORP. | 6.1M | 0.1% | −5% |
| PERCEPTIVE ADVISORS LLC | 5.1M | n/a | n/a |
| MIC Capital Management UK LLP | 4.5M | 2.5% | ±0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9M | n/a | n/a |
| Fidelity Management | 3.5M | 0.0% | +0% |
◇ AC INTELLIGENCE
Top institutional owners for NMRA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER50.4% · 0 holders
OTHER34.6% · 76 holders
DEALER / BANK5.2% · 17 holders
QUALITY / COMPOUNDER2.9% · 6 holders
TACTICAL / MACRO2.8% · 4 holders
PASSIVE / INDEX2.4% · 6 holders
SYSTEMATIC / QUANT1.7% · 4 holders
INCOME / DEFENSIVE0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for NMRA in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention NMRA yet.